Tandem Diabetes Care TNDM Accounts Receivable
Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by Tandem Diabetes Care in its filing.
Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.
The official record: Tandem Diabetes Care’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tandem Diabetes Care's accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tandem Diabetes Care's accounts receivable?
- Tandem Diabetes Care (TNDM) reported accounts receivable of $140.67M in Q1 2026.
- How has Tandem Diabetes Care's accounts receivable changed year-over-year?
- Tandem Diabetes Care's accounts receivable increased by 11.1% year-over-year, from $126.56M to $140.67M.
- What is the long-term trend for Tandem Diabetes Care's accounts receivable?
- Over 5 years (2020 to 2025), Tandem Diabetes Care's accounts receivable has grown at a 15.0% compound annual growth rate (CAGR), from $82.2M to $165.49M.
- What does accounts receivable mean?
- Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.